Search results for: 'poct cancer'

This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalen...

This study examines how global multiomics technologies are changing the way that cancer is treated, with a focus on new developments, strategic needs, and future directions. By facilitating thorough tumor characterization, early detection, patient stratification, and real-time monitoring, multiomics—an integrated analysis of genomics, transcriptomi...

03 Dec 2024  |  North America  |  Technology Research

Technology Innovations and Growth Opportunities in Breast Cancer Diagnosis

Advancing Breast Cancer Diagnosis by Leveraging Acoustic and Nonionizing Radiation Technologies

Infographics

×

Mammography and tissue biopsy have been the gold standard to detect breast cancer. Repeated mammography to assess the treatment response or disease prognosis results in frequent radiation exposure. In women with dense breasts In women with dense breasts, which have more fibrous and glandular tissues, mammograms show a white image similar to cancero...

Cancer treatment technologies are playing an instrumental role in the effective removal of cancerous tumors through radiation and non-radiation therapies. These therapies offer highly localized, minimally invasive/non-invasive, and personalized treatment options that support effective tumor removal.The growing burden of cancer cases globally—primar...

01 Jul 2016  |  Europe  |  Market Research

Western Europe Point-of-Care Testing (POCT) Market

Infographics

×

Point-of-care testing is an integral part of the IVD market that is rapidly evolving into a preferred testing mode in the EU region. POCT is a segment that presents growth opportunities for a cross-section of players, ranging from OEMs to data integrators to technology vendors. The stakeholders need to be abreast of the challenges posed by the indu...

Reduced turnaround time and potential benefits of immediate diagnosis have resulted in an increased adoption of POCT in hospitals and physician office laboratories. However, whether POC tests replace traditional laboratory tests is a question still being debated in the scientific community. This study provides the market overview, market engineerin...

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...

This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...

The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized treatment, and expanded access to testing across h...